Eija Roine1, Niilo Färkkilä2, Harri Sintonen2, Kimmo Taari3, Risto P Roine4,5, Tiina Saarto6. 1. Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland eija.roine@helsinki.fi. 2. Department of Public Health, University of Helsinki, Helsinki, Finland. 3. Department of Urology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 4. Administration, Helsinki University Hospital and University of Helsinki, Helsinki, Finland. 5. Department of Social and Health Management, University of Eastern Finland, Kuopio, Finland. 6. Comprehensive Cancer Center, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Abstract
BACKGROUND/AIM: This cross-sectional study estimated direct cancer-related health care, productivity and informal care costs for a six-month period for different states of breast cancer (BC). PATIENTS AND METHODS: A total of 827 BC patients answered a questionnaire enquiring about informal care, work capacity, and demographic factors. Direct health care resource use and productivity costs were obtained from registries. Mutually exclusive groups were formed based on disease state and time from diagnosis: primary treatment (first six months after diagnosis), rehabilitation (>six months after diagnosis), remission (>1.5 years after diagnosis), and metastatic. RESULTS: Mean total costs were: primary treatment €22,876, rehabilitation €3,456, remission €1,728, and metastatic €24,320. Mean direct health care costs were: primary treatment €11,798, rehabilitation €2,398, remission €1,147, and metastatic €13,923. Mean productivity costs varied between 18-39% and indirect costs (productivity and informal care costs) between 31-48% of the total costs. CONCLUSION: Direct medical costs were highest, but indirect costs constituted up to half of the total costs and are essential when estimating the total cost burden, as many patients are of working age. Copyright
BACKGROUND/AIM: This cross-sectional study estimated direct cancer-related health care, productivity and informal care costs for a six-month period for different states of breast cancer (BC). PATIENTS AND METHODS: A total of 827 BC patients answered a questionnaire enquiring about informal care, work capacity, and demographic factors. Direct health care resource use and productivity costs were obtained from registries. Mutually exclusive groups were formed based on disease state and time from diagnosis: primary treatment (first six months after diagnosis), rehabilitation (>six months after diagnosis), remission (>1.5 years after diagnosis), and metastatic. RESULTS: Mean total costs were: primary treatment €22,876, rehabilitation €3,456, remission €1,728, and metastatic €24,320. Mean direct health care costs were: primary treatment €11,798, rehabilitation €2,398, remission €1,147, and metastatic €13,923. Mean productivity costs varied between 18-39% and indirect costs (productivity and informal care costs) between 31-48% of the total costs. CONCLUSION: Direct medical costs were highest, but indirect costs constituted up to half of the total costs and are essential when estimating the total cost burden, as many patients are of working age. Copyright